Join the Narcan Injection group to help and get support from people like you.
Narcan Injection News
Inmates Less Likely To OD After Release If Provided Opioid Addiction Meds In Jail
FRIDAY, Sept. 12, 2025 — County jail inmates who receive medication to treat their opioid addiction have a lower risk of overdose after their release, a new study reports. They’re also significantly m...
Naloxone Implant Might Prevent Opioid Overdose
THURSDAY, Oct. 24, 2024 – Naloxone can save a person’s life by reversing a potentially fatal opioid overdose, and is now available as an over-the-counter medication. Unfortunately, there’s a very sig...
Naloxone Implant Might Prevent Opioid Overdose
THURSDAY, Oct. 24, 2024 – Naloxone can save a person’s life by reversing a potentially fatal opioid overdose, and is now available as an over-the-counter medication. Unfortunately, there’s a very sig...
Fatal Opioid-Meth Overdoses Have Fallen in U.S. by More Than a Third
TUESDAY, Oct. 22, 2024 – Expanded access to addiction treatment and the overdose-reversal med naloxone likely prompted a 37% reduction in OD deaths linked to opioids taken with meth or other...
Methadone Tied to Lower Risk for Discontinuation Versus Buprenorphine/Naloxone
FRIDAY, Oct. 18, 2024 – Receipt of methadone for opioid use disorder is associated with a lower risk for treatment discontinuation compared with buprenorphine/naloxone, according to a study...
Rate of Layperson-Administered Naloxone Increased From 2020 to 2022
WEDNESDAY, Oct. 16, 2024 – The rate of layperson-administered naloxone (LAN) increased from 2020 to 2022, according to a study published online Oct. 14 in JAMA Network Open. Christopher B. Gage, ...
More Bystanders Are Using Naloxone to Save Folks From Overdose
MONDAY, Oct. 14, 2024 – More bystanders are stepping in to administer naloxone to people who’ve overdosed on opioids, a new study shows. Nearly 25,000 OD patients received naloxone from an untrained ...
FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing
ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....
FDA Medwatch Alert: Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL in the Carpuject™ Single-use Cartridge Syringe System by Hospira: Recall - Due to the Potential Presence of Particulate Matter
ISSUE: Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe...